Insuman Rapid

What is it?

A short-acting insulin comprising human neutral insulin (crb) which is highly purified, available as a solution at a concentration of 100iu per ml, in vials, cartridges for use with pen device and as pre-prepared pens.

Medical Uses

Diabetes.

Dosage

Usually self-administered by subcutaneous injection, according to individual needs, 15 to 20 minutes before eating a meal. Effects last for about 7 to 9 hours. Cartridges or vials can Also, be given by injection in intensive care or similar circumstances where patient's condition is being closely monitored.

Special Care

Kidney or liver disease, patients transferring from animal insulins (should be warned that early signs of hypoglycaemia may not be so apparent). Infections, illnesses, stress, emotional upset, pregnancy, change in insulin source, type etc; in all these cases, dose adjustments may be needed.

Possible Drug and Food Interactions

Oral contraceptives, MAOIs, alcohol, β-blockers, corticotrophin, diuretics, corticosteroids.

Known Side Effects

Lipodystrophy (changes involving fat deposition) at injection site. Any adverse side effects should be reported to the Committee on the Safety of Medicines (CSM).

Manufacturer

Aventis.